Sign in

CIK 0000072444

  • Accelerated filer
  • Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
591212264
Phone
+1 650-550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-02-13 Tucker Sean Chief Scientific Officer Grant or award · Stock Option (right to buy) +4,027 4,027
2018-02-13 Tucker Sean Chief Scientific Officer Grant or award · Stock Option (right to buy) +1,006 1,006
2018-02-13 Tucker Sean Chief Scientific Officer Grant or award · Stock Option (right to buy) +3,020 3,020
2018-02-13 Tucker Sean Chief Scientific Officer Grant or award · Stock Option (right to buy) +10,523 10,523
2018-02-13 Tucker Sean Chief Scientific Officer Grant or award · Stock Option (right to buy) +11,604 11,604
2018-02-13 Tucker Sean Chief Scientific Officer Grant or award · Stock Option (right to buy) +10,067 10,067
2018-02-13 Tucker Sean Chief Scientific Officer Grant or award · Stock Optin (right to buy) +7,731 7,731
2018-02-13 Tucker Sean Chief Scientific Officer Grant or award · Stock Optin (right to buy) +9,060 9,060
2018-02-13 Latour Wouter President and Chief Executive Grant or award · Stock Option (right to buy) +6,536 6,536
2018-02-13 Latour Wouter President and Chief Executive Grant or award · Stock Option (right to buy) +9,442 9,442
2018-02-13 Latour Wouter President and Chief Executive Grant or award · Stock Option (right to buy) +13,256 13,256
2018-02-13 Latour Wouter President and Chief Executive Grant or award · Stock Option (right to buy) +14,908 14,908
2018-02-13 Latour Wouter President and Chief Executive Grant or award · Stock Option (right to buy) +18,120 18,120
2018-02-13 Latour Wouter President and Chief Executive Grant or award · Stock Option (right to buy) +10,731 10,731
2018-02-13 Latour Wouter President and Chief Executive Grant or award · Stock Option (right to buy) +23,651 23,651
2018-02-13 Harland John M Chief Financial Officer Grant or award · Stock Option (right to buy) +9,563 9,563
2018-02-13 Harland John M Chief Financial Officer Grant or award · Stock Option (right to buy) +8,255 8,255
2018-02-13 Harland John M Chief Financial Officer Grant or award · Stock Option (right to buy) +4,087 4,087
2018-02-13 Harland John M Chief Financial Officer Grant or award · Stock Option (right to buy) +7,047 7,047
2018-02-13 Finney Michael J. Director Grant or award +228,978 228,978

Page 21 of 23 · 442 trades